chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Starting on 4/8/21 around 9:00 PM my body started to feel slightly sore and I had a low grade temperature of 99.6. Throughout the night my body became extremely sensitive and sore especially in my lower back and neck. My temperature also continued to rise to 103.0.  Throughout the day of 4/9/21 I was taking Tylenol and ibuprofen on a rotating schedule. My temperature went up and down throughout the day spiking at 105.7 and dropping down to 101.2. Around 10:00 PM it was around 102.9 and my body was becoming even weaker. This morning, now 36 hours after my symptoms started, I can barely lift my arm, my headache has worsened, my total soreness and weakness is no better and my temperature is 102.3.  I have also had trouble with staying hydrated because my skin hurts if it is not covered from the air and I get heavy chills,  but when I cover up I am profusely sweating constantly. The sweat is so bad, I constantly have to lay on a towel and change my clothes.
Severe headaches, pain in neck and shoulders. Started a few days after got SHINGRIX at a pharmacy. Headaches not fully resolved 3 months later.
DIFFICULT TO BREATHE; STRESS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 04-MAR-2021 02:00 for prophylactic vaccination. he batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On 04-MAR-2021, the subject experienced difficult to breathe. On 04-MAR-2021, the subject experienced stress. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from difficult to breathe, and stress. This report was non-serious.; Sender's Comments: V0:Medical assessment comment not required as per standard procedure as the case is assessed as Non-serious. .
itching intensely all over his body; just a lot of intense itching; he feels like even his eye balls are itching; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received BNT162b2 (BNT162B2), on 08Apr2022 at 18:00 as dose number unknown, single (Lot number: FJ9943) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PRURITUS (non-serious) with onset 08Apr2022, outcome "unknown", described as "itching intensely all over his body; just a lot of intense itching; he feels like even his eye balls are itching".  Additional information: Reporter stated, "My husband and myself (Further clarifications unknown) received the Pfizer COVID Vaccine at about 6 'O' clock this evening. My husband is now having, he doesn't have a rash but he is itching intensely all over his body but there is no rash. It's just a lot of intense itching. He said even, he feels like even his eyeballs are itching, is that any, I can't find anything about that being reported."  No follow-up attempts are possible. No further information is expected.
I had a double dose 23Mar2021, 29Apr2021 then boosted Nov2021. Came down with COVID-19 on 20Jun2022; I had a double dose 23Mar2021, 29Apr2021 then boosted Nov2021. Came down with COVID-19 on 20Jun2022; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID. The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), on 23Mar2021 as dose 1, single (Batch/Lot number: unknown), on 29Apr2021 as dose 2, single (Batch/Lot number: unknown) and in Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 20Jun2022, outcome "unknown" and all described as "I had a double dose 23Mar2021, 29Apr2021 then boosted Nov2021. Came down with COVID-19 on 20Jun2022". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (20Jun2022) UNKNOWN RESULTS, notes: Came down with COVID-19 on 20Jun2022. Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This spontaneous report as received from a Licensed Vocational Nurse refers to a patient of unknown age and gender with a medical history and drug allergies not reported, who on 15-NOV-2012, was vaccinated with dose 1 GARDASIL (lot #, dose and route not provided). On 21-DEC-2012, was vaccinated with dose 2 GARDASIL (lot #, dose and route not provided). No other co-suspects were reported. No concomitant medications were reported. The nurse, reported there not was adverse symptoms. Additional information has been requested.
Extreme fatigue at 7:30, as I was finishing dinner.   I felt like was getting a fever due to a bad cold, but I didn't have a fever, I just felt warm.  I took three Advil and went to bed at 10:00, but staying awake after 9:00 was very difficult.  Normal bedtime is 11:30.  I woke at 3:15 AM with my entire back feeling sore, and still feeling feverish, but had no fever.  Three more Advil, and I slept until my alarm went off at 7:00 AM.  I still felt tired this morning (11/7), but was able to drive safely.  I walked for about two hours, and felt very tired, which is very unusual, as I often hike 6-9 miles without fatigue.  Lunch and Advil helped.   Dinner and more Advil at 7:00 PM.  As I write this at 9:30 PM, I feel pretty good.  However, I noticed a large (2.5" diameter) red circle around the injection site as I prepared for bed.  It is very tender and warm, and slightly swollen.
Starting 02/01/2022, I had some breathing issues, mild cough, fatigue and I felt feverish. I started taking a homeopathic remedy that night. I tested positive for COVID-19 02/02/2022. My temps varied from 99-101. During this episode, the highest my temp got was 101.5. This variation lasted from 02/02 - 02/17. I had monoclonal antibodies on 02/17/2022 and then my temperatures stayed normal since then. Mostly all of my symptoms were dissipating by 02/18/2022.
Sharp pain in elbow / severe pain in right elbow/ pain in ankle; like ankle was breaking / ankle like was broke; Pain in cheek / severe pain in my cheek; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID. The reporter is the patient.  An 83-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 23Sep2022 as dose 4 (booster), single (Lot number: GJ2524) at the age of 83 years for covid-19 immunisation. The patient's relevant medical history included: "Flu" (unspecified if ongoing), notes: Gets flu very badly every year. Concomitant medication(s) included: ELIQUIS; CARTIA [DILTIAZEM HYDROCHLORIDE]; LOSARTAN; METFORMIN; LEVOTHYROXINE; METAMUCIL [PSYLLIUM HYDROPHILIC MUCILLOID]. Vaccination history included: BNT162b2 (1st dose, Lot number: EL9265), administration date: 09Feb2021, when the patient was 82-year-old, for Covid-19 immunization; BNT162b2 (2nd dose, Lot number: EN6200), administration date: 02Mar2021, when the patient was 82-year-old, for Covid-19 immunization; BNT162b2 (3rd dose, Lot number: FF2589), administration date: 14Oct2021, when the patient was 82-year-old, for Covid-19 immunization. The following information was reported: FACIAL PAIN (non-serious) with onset Sep2022, outcome "recovered", described as "Pain in cheek / severe pain in my cheek"; ARTHRALGIA (non-serious) with onset Sep2022, outcome "recovered", described as "Sharp pain in elbow / severe pain in right elbow/ pain in ankle; like ankle was breaking / ankle like was broke". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Patient experienced severe pain in random parts of the body that goes away after couple of seconds. The pain was in her right elbow, left cheek, and right ankle. The first time she had experienced it on her elbow, like a lightning bolt hit her elbow and it hurts so bad and nearly dropped to ground and then was gone like after 2 seconds. Then a few days later, she had severe pain in her cheek, no teeth involvement, lasted for 1-2 sec and was gone. The other day she was walking at the mall she got such a severe pain in her ankle and thought she broke her ankle. She just stood a minute and then it went away. Events started a couple days after the shot right after like 2-3 days. She stated that it never happened to her and haven't take any shot aside from the covid-19 vaccine. Patient wanted to know if she can get her flu vaccine on top of the vaccine, if it is safe to get it. She's planning to have it at the end of this week or next week. She also mentioned that she is going in next few days for an appointment and wants blood work done and is due for the blood work.
Initial report received from a health care professional on 11 September 2012. A 80 something-year-old female patient, whose illness at the time of vaccination was unknown, had received a first dose of intramuscular FLUZONE HD (lot number, anatomical site of vaccination were not reported) on 01 September 2012. On an unspecified date, the patient developed low grade fever, headache, nausea, malaise, body aches, swollen arm and shoulder pain. The events of low grade fever, headache, nausea, malaise, body aches, swollen arm and shoulder pain were persisting. Corrective treatment was not reported. List of documents held by the sender none.
Headache, HYPERtension, Syncope, COLD, CHILLS, FATIGUE Narrative:
PT received injection of Pneumovax 0.5 3/22/03. PT noticed rash/itching on 3/25/03. Oral flat pink - red lesion over body. PT Dx'd with pneumonia 3/21/03. Received Rocephine 3/21/03. Received Pneumovax 3/22/03. PT started 2 pak 3/22/03.
a rash appeared at injection site that is warm to the touch and feels as though a knot is under the skin; a rash appeared at injection site that is warm to the touch and feels as though a knot is under the skin; a rash appeared at injection site that is warm to the touch and feels as though a knot is under the skin; cellulitis; This is a spontaneous report from a contactable consumer (patient). This 32-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 08Apr2021 at 12:45 PM (lot ER8729), at the age of 32 years, as the first single dose, in left arm, for COVID-19 immunisation. Medical history included dermatographia and sulfa & contrast dye allergies. The patient did not have COVID prior vaccination. Concomitant medication included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL). No other vaccine was administered in four weeks. On 17Apr2021 at 12:00 PM, 9 days after vaccination, a rash appeared at injection site that was warm to the touch and felt as though a knot was under the skin. On 20Apr2021 the rash was bigger in size. Treatment was received for the adverse event and included Kelfex antibiotics for cellulitis. The events resulted in Doctor or other healthcare professional office/clinic visit. COVID was not tested post vaccination. The patient had not yet recovered.
PATIENT STATES THAT ~3DAYS AFTER VACCINATION SHE EXPERIENCED SWELLING IN THE MORNING (IN THE HANDS, KNEES AND FEET), RASH AT INJECTION SITE, HEADACHE, HIVE AND ITCHING.  2 WEEKS LATER (7/24/22) PATIENTS STATES SHE IS STILL HAVING THE ISSUE.
motor tics x 7 days and vocal tics beginning at day 8 simultaneously with motor tics
10-12 hours after getting the shot I started to experience body aches, chills, and fever.  These symptoms lasted through the night.  The following day I felt better but had no energy.  It was a one day thing.  I've felt fine since then.
Patient reports after first dose on 4/8/21 they had red rash on left arm, itchiness at site of injection, then itchiness spread over face and body and lasted for one week. Then on 4/28/21 patient had swelling in their thighs and went to the ER and was diagnosed with Urinary Tract Infection.   Patient reports after second dose of pfizer on 5/8/21 getting headache, joint pain, fever, cough, itchiness all over body/face, under right armpit. Symptoms started between 4-7pm on Saturday 5/8/21. Patient reports having fatigue on Sunday 5/9/21 and Monday 5/10/21. Patient  self treated at home and took tylenol, ketorolac, and benadryl for symptoms.
c/o being light headed as soon as she received Varivax (the 3rd vaccine) she arched backward lost consciousness briefly. When she was laid flat on the examining table with legs raised she recovered quickly. Before she was laid Flat she had a generalized body spasm.
High blood pressure, increased heart rate, chest pains and light-headedness.  I ended up in local Hospital overnight and underwent several tests including chest x-rays, EKG's, stress test, CT-scan and was placed on morphine for the chest pains.  I was discharged from the hospital and placed on Amlodipine Besylate 5 mg, Pantoprazole Sodium Ec 40 mg, given Albuterol Sulfate 108 Mcg/Act Aer Pras but was provided with a Breo Ellipta by HCP when I went to see him the following day as a follow-up to my hospital stay.
Left arm "killing me", Chills, headache, myalgia, fatigue, nausea
7/12/21 breakthrough covid case. I did become ill with headache, bronchitis like cough, asthma exacerbation and extreme fatigue. I got ahead of the worst of the cough and headache after about 6 days. I treated at home with Sudafed, Mucinex, ibuprofen, and iprotropium bromide Albuterol Sulfate nebulizer. I was on prednisone and augmentin for a sinus infection I saw my ENT for on 7/7. I had a negative at home covid test 7/6 with that sinus infection. I felt completely different in 7/12 as my covid symptoms set in. My primary care physician extended the prednisone upon my covid dx.   The fatigue and asthma tightness remained an issue for a couple of weeks as did off and on slight headaches. On 8/16 I saw my dr to check in on my asthma. My lungs sounded clear, we added a steroid inhaler twice a day and I stayed on my nebulizer.   Of note, our 7 year old showed first signs cough and 101 temp and tested 7/11 positive. Our 11 year old was tested same time out of caution and was positive also. He had a 100.4 temp at the urgent care as we took her in.  My husband and I PCR tested positive the morning of 7/12, initially just some throat clearing for him, we both became symptomatic sick the evening of the 12th.
This spontaneous report as received from a health professional refers to a 30 year old male patient. On 17-NOV-2014, the patient was inadvertently vaccinated with a dose of (Merck) PROQUAD (lot#, expiration date and site of administration were not reported), subcutaneously. No adverse effects were reported. Additional information has been requested.
Parent gave daughter Advil every 6 hours past injection. Last dose at 2:00am 8/17/06. At 8:30am daughter temp 102. Advised parent to consult with PMD regarding increased temp.
This case was reported by a consumer via call center representative and described the occurrence of feeling unwell in a female patient who received SHINGRIX for prophylaxis. On 24th December 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced feeling unwell. On an unknown date, the outcome of the feeling unwell was not reported. It was unknown if the reporter considered the feeling unwell to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient felt very sick after the dose of SHINGRIX. The patient disconnected before providing any additional information. Call Notes: Caller only provided first name. She disconnected before providing any additional information.
States left arm deltoid region extremely painful. Started day of injection and continues on - now 5 days post injection.  Patient states numbness in hand.  Has decreased grip in left hand.
1 week after administration of the vaccine patient had developed right lower extremity pain, chest pain and shortness of breath.  He was diagnosed with a right lower extremity deep venous thrombosis and bilateral pulmonary emboli.  He had no known underlying thromboembolic disease or provoking situation
Numbness and tingling in little, ring and middle fingers on side that injection was (left upper arm); Numbness and tingling in little, ring and middle fingers on side that injection was (left upper arm); This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 26Apr2021 at 11:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included depression, anorexia, bradycardia and known allergy to latex and sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included fluoxetine (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN) and spironolactone (MANUFACTURER UNKNOWN); all from unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 05Apr2021 at 11:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation and received amoxicillin antibiotics (MANUFACTURER UNKNOWN) for unknown indication on unknown date and experienced drug allergy. On 26Apr2021 at 11:45, the patient experienced numbness and tingling in little, ring and middle fingers on side that injection was (left upper arm),which the patient noticed after she had left the observation area and returned to her vehicle. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events numbness and tingling in little, ring and middle fingers on side that injection was (left upper arm) was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
p/ pt recv vax approx 3yrs later pt devel vesicular papules, itchy lesions over body. treated w/acyclovir
Left side chest pain began Monday October 25 2021 Reported to ER around 11am Admitted to hospital with elevated troponins and ckrs, normal ekgs and chest xrays Myocarditis  diagnosis confirmed
tongue swelling, R arm swelling, b/l arm hives 13h after immunziation
the rash was worse; torso very itchy for 1 week; scattered red spots urticaria; Initial information received on 15-Mar-2021 regarding an unsolicited valid non-serious case received from a other health professional.   This case involves a 80 year old female patient who experienced the rash was worse (rash), torso very itchy for 1 week (pruritus) and scattered red spots urticarial (urticaria), while she received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  Medical history included Rash.  Medical treatment, vaccination, concomitant medication and family history were not provided.  On 18-Oct-2019, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE (lot UJ233AA and expiry date: not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious the rash was worse (rash), torso very itchy for one week (pruritus) and diagnosis scattered red spots urticaria (urticaria), (unknown latency) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE.  It was also reported that the nurse is calling today, because the patient son called the office and asked about the patient (his mom) getting the Covid (coronavirus diseases) Vaccine. During the call, the son of the patient mentioned that his mom had an allergic reaction to the Fluzone Quadrivalent vaccine and questioned if any of the ingredients of the Covid vaccine and the Fluzone Quadrivalent vaccine are the same. Reporter relationship: health care professional (HCP), Product used: Used First time product used: yes still using product: no Was Device Used: yes  Details of laboratory data not reported.   The patient was treated with BILASTINE (BLEXTEN) (anti-allergy medication).  At the time of reporting, the outcome of events was reported as unknown.
Blurred vision; This case was reported by a consumer via(Shingrix GSK Chatbot) call center representative and described the occurrence of blurred vision in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced blurred vision. On an unknown date, the outcome of the blurred vision was unknown.   It was unknown if the reporter considered the blurred vision to be related to Shingrix.  Additional details were reported as follows: This case was reported by the patient for himself/herself. The age at vaccination was not reported. The patient reported that he/she had blurred vision after receiving Shingrix. The patient asked if there was any possibility of this as the patient could see clearly without spect than with it.
0.2ml COVID vaccine (monovalent 6mo-4yryr) withdrawn from vial and given to patient at approx 830am. This vial should have been diluted per manufacturer instruction. Vial was not diluted prior to administration.  Error discovered at approx 115pm. Parents called and told of error and advised to watch for increased reaction after shot. I called dad on 1/25/23 at approx 1030am. He stated patient had increased lethargy and chills following the vaccine. Dad stated that symptoms were continuing to improve since 1/23/23. Pt also should have had bivalent dose as 3rd dose but was given a 3rd monovalent dose.
Hive rash started 09/22/2005, Benadryl 3/4 1 tsp every 6-8 hrs x 24 hrs until hives resolve.
Case number PHEH2017US003416, Is an initial spontaneous report received from a nurse on 31 Jan 2017. This report refers to a 03 years old male patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with FLUCELVAX Quadrivalent (batch number: 185886, Expiry date: 30 Apr 2017) at a dose of 0.5 ml Intramuscularly on 20 Oct 2016. On the same day a 03 year old child patient received treatment with FLUCELVAX Quadrivalent. No adverse event was reported following this administration error (drug administered to patient of inappropriate age).
slurring of words, sleeping all day, hallucination, difficalt walking, and falling. This lasted for about 12 hours On September 16 and 17 arm that shot was given in hurt badly and on the 17th two red spots showed up on arm.
Case number PHEH2013US003319 is an initial spontaneous report received from a nurse on 07 Feb 2013. This report refers to an 11-years-old male patient. It was reported that he received only MenCYW-135 liquid component of MENVEO (batch number: M11077) intramuscularly on 24 Jan 2013 and did not receive MenA lyophilized conjugate. No adverse reactions were reported following the maladministration.